학술논문

Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.
Document Type
Article
Source
Journal of Medicinal Chemistry; 4/28/2022, Vol. 65 Issue 8, p6001-6016, 16p
Subject
Language
ISSN
00222623